Slow-k and Zoledronic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Slow-k (potassium chloride) and Zoledronic (zoledronic acid). Common drug interactions include upper respiratory tract infection among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Slow-k and Zoledronic. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Slow-k?

Slow-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 3,683 Slow-k users. Check the latest studies of Slow-k.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

On Jul, 26, 2026

15 people who take Slow-k and Zoledronic together, and have interactions are studied.

Slow-k and Zoledronic drug interactions.

What are the common drug interactions of Slow-K and Zoledronic, by gender? *:

female:

Upper respiratory tract infection
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Electrocardiogram qt prolonged
Oedema peripheral (superficial swelling)
Death
Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)
Peripheral swelling
Chest injury

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Pyrexia (fever)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Plasma cell myeloma (cancer that begins in plasma cells)
White blood cell count decreased

What are the common drug interactions of Slow-K and Zoledronic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

n/a

60+:

Sepsis (a severe blood infection that can lead to organ failure and death)
Pyrexia (fever)
Oedema peripheral (superficial swelling)
Skin warm
Upper respiratory tract infection
Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Plasma cell myeloma (cancer that begins in plasma cells)
White blood cell count decreased
Azotaemia (excess of urea or other nitrogenous compounds in the blood)

What are the existing conditions these people have? *

Constipation: 9 people, 60.00%
Urinary Tract Infection: 7 people, 46.67%
Nausea (feeling of having an urge to vomit): 7 people, 46.67%
Blood Potassium Decreased: 7 people, 46.67%
Bone Disorder: 7 people, 46.67%
Cancer Pain: 7 people, 46.67%
Cough: 7 people, 46.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 46.67%
Gout (uric acid crystals building up in the body): 7 people, 46.67%
Blood Phosphorus Decreased: 7 people, 46.67%

* Approximation only. Some reports may have incomplete information.

Do you take Slow-k and Zoledronic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously